Activation of macrophages by P2X7-induced microvesicles from myeloid cells is mediated by phospholipids and is partially dependent on TLR4

Journal of Immunology

Volumn 185, Issue 6, 2010, Pages 3740-3749

  Thomas, L Michael ^a   Salter, Russell D ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM INDEPENDENT PHOSPHOLIPASE A2; CALCIUM IONOPHORE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHOLIPASE D; PHOSPHOLIPID; PURINERGIC P2X7 RECEPTOR; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; HIGH MOBILITY GROUP B1 PROTEIN; TLR4 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; CELL ACTIVATION; CELL FREE SYSTEM; CELL ISOLATION; MACROPHAGE; MICROVASCULATURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SUPERNATANT; ANIMAL; C57BL MOUSE; CELL LINE; GENETICS; HUMAN; IMMUNOLOGY; MACROPHAGE ACTIVATION; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; SECRETION; SECRETORY VESICLE; SIGNAL TRANSDUCTION;

ANIMALS; BONE MARROW CELLS; CELL LINE; HMGB1 PROTEIN; HUMANS; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID CELLS; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOLIPIDS; RECEPTORS, PURINERGIC P2X7; SECRETORY VESICLES; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 78649853114     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1001231     Document Type: Article

References (67)

1. Cocucci, E., G. Racchetti, and J. Meldolesi. 2009. Shedding microvesicles: artefacts no more. Trends Cell Biol. 19: 43-51.
2. Bianco, F., E. Pravettoni, A. Colombo, U. Schenk, T. Möller, M. Matteoli, and C. Verderio. 2005. Astrocyte-derived ATP induces vesicle shedding and IL-1 beta release from microglia. J. Immunol. 174: 7268-7277. (Pubitemid 40705696)
3. Pizzirani, C., D. Ferrari, P. Chiozzi, E. Adinolfi, D. Sandonà, E. Savaglio, and F. Di Virgilio. 2007. Stimulation of P2 receptors causes release of IL-1beta-loaded microvesicles from human dendritic cells. Blood 109: 3856-3864. (Pubitemid 46641737)
4. Baj-Krzyworzeka, M., R. Szatanek, K. Weglarczyk, J. Baran, B. Urbanowicz, P. Brański, M. Z. Ratajczak, and M. Zembala. 2006. Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes. Cancer Immunol. Immunother. 55: 808-818.
5. Pilzer, D., and Z. Fishelson. 2005. Mortalin/GRP75 promotes release of membrane vesicles from immune attacked cells and protection from complement-mediated lysis. Int. Immunol. 17: 1239-1248.
6. Sidhu, S. S., A. T. Mengistab, A. N. Tauscher, J. LaVail, and C. Basbaum. 2004. The microvesicle as a vehicle for EMMPRIN in tumor-stromal interactions. Oncogene 23: 956-963.
7. Andrei, C., C. Dazzi, L. Lotti, M. R. Torrisi, G. Chimini, and A. Rubartelli. 1999. The secretory route of the leaderless protein interleukin 1beta involves exocytosis of endolysosome-related vesicles. Mol. Biol. Cell 10: 1463-1475.
8. Andrei, C., P. Margiocco, A. Poggi, L. V. Lotti, M. R. Torrisi, and A. Rubartelli. 2004. Phospholipases C and A2 control lysosome-mediated IL-1β secretion: implications for inflammatory processes. Proc. Natl. Acad. Sci. USA 101: 9745-9750.
9. + T lymphocytes induce polarized exocytosis of secretory lysosomes by dendritic cells with release of interleukin-1beta and cathepsin D. Blood 98: 2152-2159.
10. Théry, C., M. Ostrowski, and E. Segura. 2009. Membrane vesicles as conveyors of immune responses. Nat. Rev. Immunol. 9: 581-593.
11. Qu, Y., L. Franchi, G. Nunez, and G. R. Dubyak. 2007. Nonclassical IL-1 beta secretion stimulated by P2X7 receptors is dependent on inflammasome activation and correlated with exosome release in murine macrophages. J. Immunol. 179: 1913-1925.
12. Qu, Y., L. Ramachandra, S. Mohr, L. Franchi, C. V. Harding, G. Nunez, and G. R. Dubyak. 2009. P2X7 receptor-stimulated secretion of MHC class II-containing exosomes requires the ASC/NLRP3 inflammasome but is independent of caspase-1. J. Immunol. 182: 5052-5062.
13. Baroni, M., C. Pizzirani, M. Pinotti, D. Ferrari, E. Adinolfi, S. Calzavarini, P. Caruso, F. Bernardi, and F. Di Virgilio. 2007. Stimulation of P2 (P2X7) receptors in human dendritic cells induces the release of tissue factor-bearing microparticles. FASEB J. 21: 1926-1933.
14. MacKenzie, A., H. L. Wilson, E. Kiss-Toth, S. K. Dower, R. A. North, and A. Surprenant. 2001. Rapid secretion of interleukin-1beta by microvesicle shedding. Immunity 15: 825-835.
15. Wilson, H. L., S. E. Francis, S. K. Dower, and D. C. Crossman. 2004. Secretion of intracellular IL-1 receptor antagonist (type 1) is dependent on P2X7 receptor activation. J. Immunol. 173: 1202-1208.
16. Brough, D., and N. J. Rothwell. 2007. Caspase-1-dependent processing of prointerleukin-1beta is cytosolic and precedes cell death. J. Cell Sci. 120: 772-781.
17. Hogquist, K. A., E. R. Unanue, and D. D. Chaplin. 1991. Release of IL-1 from mononuclear phagocytes. J. Immunol. 147: 2181-2186.
18. Singer, I. I., S. Scott, J. Chin, E. K. Bayne, G. Limjuco, J. Weidner, D. K. Miller, K. Chapman, and M. J. Kostura. 1995. The interleukin-1 beta-converting enzyme (ICE) is localized on the external cell surface membranes and in the cytoplasmic ground substance of human monocytes by immuno-electron microscopy. J. Exp. Med. 182: 1447-1459.
19. Martinon, F., A. Mayor, and J. Tschopp. 2009. The inflammasomes: guardians of the body. Annu. Rev. Immunol. 27: 229-265.
20. Baj-Krzyworzeka, M., R. Szatanek, K. Weglarczyk, J. Baran, and M. Zembala. 2007. Tumour-derived microvesicles modulate biological activity of human monocytes. Immunol. Lett. 113: 76-82.
21. Valenti, R., V. Huber, P. Filipazzi, L. Pilla, G. Sovena, A. Villa, A. Corbelli, S. Fais, G. Parmiani, and L. Rivoltini. 2006. Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes. Cancer Res. 66: 9290-9298.
22. Chu, J., L. M. Thomas, S. C. Watkins, L. Franchi, G. Núñez, and R. D. Salter. 2009. Cholesterol-dependent cytolysins induce rapid release of mature IL-1beta from murine macrophages in a NLRP3 inflammasome and cathepsin Bdependent manner. J. Leukoc. Biol. 86: 1227-1238.
23. Radin, M. S., S. Sinha, B. A. Bhatt, N. Dedousis, and R. M. O'Doherty. 2008. Inhibition or deletion of the lipopolysaccharide receptor Toll-like receptor-4 confers partial protection against lipid-induced insulin resistance in rodent skeletal muscle. Diabetologia 51: 336-346.
24. Englert, J. M., L. E. Hanford, N. Kaminski, J. M. Tobolewski, R. J. Tan, C. L. Fattman, L. Ramsgaard, T. J. Richards, I. Loutaev, P. P. Nawroth, et al. 2008. A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis. Am. J. Pathol. 172: 583-591.
25. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37: 911-917.
26. Christie, W. W. 1982. A simple procedure for rapid transmethylation of glycerolipids and cholesteryl esters. J. Lipid Res. 23: 1072-1075.
27. Pelegrin, P., C. Barroso-Gutierrez, and A. Surprenant. 2008. P2X7 receptor differentially couples to distinct release pathways for IL-1beta in mouse macrophage. J. Immunol. 180: 7147-7157.
28. Donnelly-Roberts, D. L., M. T. Namovic, P. Han, and M. F. Jarvis. 2009. Mammalian P2X7 receptor pharmacology: comparison of recombinant mouse, rat and human P2X7 receptors. Br. J. Pharmacol. 157: 1203-1214.
29. Park, J. S., D. Svetkauskaite, Q. He, J. Y. Kim, D. Strassheim, A. Ishizaka, and E. Abraham. 2004. Involvement of Toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J. Biol. Chem. 279: 7370-7377.
30. Termeer, C., F. Benedix, J. Sleeman, C. Fieber, U. Voith, T. Ahrens, K. Miyake, M. Freudenberg, C. Galanos, and J. C. Simon. 2002. Oligosaccharides of hyaluronan activate dendritic cells via Toll-like receptor 4. J. Exp. Med. 195: 99-111.
31. Vogl, T., K. Tenbrock, S. Ludwig, N. Leukert, C. Ehrhardt, M. A. van Zoelen, W. Nacken, D. Foell, T. van der Poll, C. Sorg, and J. Roth. 2007. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat. Med. 13: 1042-1049.
32. Andersson, U., H. Wang, K. Palmblad, A. C. Aveberger, O. Bloom, H. Erlandsson-Harris, A. Janson, R. Kokkola, M. Zhang, H. Yang, and K. J. Tracey. 2000. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J. Exp. Med. 192: 565-570.
33. Wang, H., O. Bloom, M. Zhang, J. M. Vishnubhakat, M. Ombrellino, J. Che, A. Frazier, H. Yang, S. Ivanova, L. Borovikova, et al. 1999. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285: 248-251.
34. Scaffidi, P., T. Misteli, and M. E. Bianchi. 2002. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418: 191-195.
35. Gardella, S., C. Andrei, D. Ferrera, L. V. Lotti, M. R. Torrisi, M. E. Bianchi, and A. Rubartelli. 2002. The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep. 3: 995-1001.
36. Hu, S. P., C. Harrison, K. Xu, C. J. Cornish, and C. L. Geczy. 1996. Induction of the chemotactic S100 protein, CP-10, in monocyte/macrophages by lipopolysaccharide. Blood 87: 3919-3928.
37. Xu, K., and C. L. Geczy. 2000. IFN-gamma and TNF regulate macrophage expression of the chemotactic S100 protein S100A8. J. Immunol. 164: 4916-4923.
38. Zheng, L., T. E. Riehl, and W. F. Stenson. 2009. Regulation of colonic epithelial repair in mice by Toll-like receptors and hyaluronic acid. Gastroenterology 137: 2041-2051.
39. Lotze, M. T., and K. J. Tracey. 2005. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat. Rev. Immunol. 5: 331-342.
40. Akira, S., and K. Takeda. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4: 499-511.
41. Steinberg, S. F. 2008. Structural basis of protein kinase C isoform function. Physiol. Rev. 88: 1341-1378.
42. Taylor, S. S., J. Yang, J. Wu, N. M. Haste, E. Radzio-Andzelm, and G. Anand. 2004. PKA: a portrait of protein kinase dynamics. Biochim. Biophys. Acta 1697: 259-269.
43. Alzola, E., A. Pérez-Etxebarria, E. Kabré, D. J. Fogarty, M. Métioui, N. Chaïb, J. M. Macarulla, C. Matute, J. P. Dehaye, and A. Marino. 1998. Activation by P2X7 agonists of two phospholipases A2 (PLA2) in ductal cells of rat submandibular gland: coupling of the calcium-independent PLA2 with kallikrein secretion. J. Biol. Chem. 273: 30208-30217.
44. Humphreys, B. D., and G. R. Dubyak. 1996. Induction of the P2z/P2X7 nucleotide receptor and associated phospholipase D activity by lipopolysaccharide and IFN-gamma in the human THP-1 monocytic cell line. J. Immunol. 157: 5627-5637.
45. Panupinthu, N., L. Zhao, F. Possmayer, H. Z. Ke, S. M. Sims, and S. J. Dixon. 2007. P2X7 nucleotide receptors mediate blebbing in osteoblasts through a pathway involving lysophosphatidic acid. J. Biol. Chem. 282: 3403-3412.
46. Lee, H., J. J. Liao, M. Graeler, M. C. Huang, and E. J. Goetzl. 2002. Lysophospholipid regulation of mononuclear phagocytes. Biochim. Biophys. Acta 1582: 175-177.
47. Lin, W. W., S. H. Chang, and S. M. Wang. 1999. Roles of atypical protein kinase C in lysophosphatidic acid-induced type II adenylyl cyclase activation in RAW 264.7 macrophages. Br. J. Pharmacol. 128: 1189-1198.
48. Domercq, M., A. Perez-Samartin, D. Aparicio, E. Alberdi, O. Pampliega, and C. Matute. 2010. P2X7 receptors mediate ischemic damage to oligodendrocytes. Glia 58: 730-740.
49. Idzko, M., H. Hammad, M. van Nimwegen, M. Kool, M. A. Willart, F. Muskens, H. C. Hoogsteden, W. Luttmann, D. Ferrari, F. Di Virgilio, et al. 2007. Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells. Nat. Med. 13: 913-919.
50. Mortaz, E., S. Braber, M. Nazary, M. E. Givi, F. P. Nijkamp, and G. Folkerts. 2009. ATP in the pathogenesis of lung emphysema. Eur. J. Pharmacol. 619: 92-96.
51. Peng, W., M. L. Cotrina, X. Han, H. Yu, L. Bekar, L. Blum, T. Takano, G. F. Tian, S. A. Goldman, and M. Nedergaard. 2009. Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury. Proc. Natl. Acad. Sci. USA 106: 12489-12493.
52. Söderberg, A., A. M. Barral, M. Söderström, B. Sander, and A. Rosén. 2007. Redox-signaling transmitted in trans to neighboring cells by melanoma-derived TNF-containing exosomes. Free Radic. Biol. Med. 43: 90-99.
53. Qu, Y., and G. R. Dubyak. 2009. P2X7 receptors regulate multiple types of membrane trafficking responses and non-classical secretion pathways. Purinergic Signal. 5: 163-173.
54. Bauernfeind, F. G., G. Horvath, A. Stutz, E. S. Alnemri, K. MacDonald, D. Speert, T. Fernandes-Alnemri, J. Wu, B. G. Monks, K. A. Fitzgerald, et al. 2009. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J. Immunol. 183: 787-791.
55. Moore, S. F., and A. B. MacKenzie. 2007. Murine macrophage P2X7 receptors support rapid prothrombotic responses. Cell. Signal. 19: 855-866.
56. Stewart, C. R., L. M. Stuart, K. Wilkinson, J. M. van Gils, J. Deng, A. Halle, K. J. Rayner, L. Boyer, R. Zhong, W. A. Frazier, et al. 2010. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat. Immunol. 11: 155-161.
57. Nowicki, M., K. Müller, H. Serke, J. Kosacka, C. Vilser, A. Ricken, and K. Spanel-Borowski. 2010. Oxidized low-density lipoprotein (oxLDL)-induced cell death in dorsal root ganglion cell cultures depends not on the lectin-like oxLDL receptor-1 but on the Toll-like receptor-4. J. Neurosci. Res. 88: 403-412.
58. Serke, H., C. Vilser, M. Nowicki, F. A. Hmeidan, V. Blumenauer, K. Hummitzsch, A. Lösche, and K. Spanel-Borowski. 2009. Granulosa cell subtypes respond by autophagy or cell death to oxLDL-dependent activation of the oxidized lipoprotein receptor 1 and Toll-like 4 receptor. Autophagy 5: 991-1003.
59. Chen, S., R. Sorrentino, K. Shimada, Y. Bulut, T. M. Doherty, T. R. Crother, and M. Arditi. 2008. Chlamydia pneumoniae-induced foam cell formation requires MyD88-dependent and -independent signaling and is reciprocally modulated by liver X receptor activation. J. Immunol. 181: 7186-7193.
60. Bae, Y. S., J. H. Lee, S. H. Choi, S. Kim, F. Almazan, J. L. Witztum, and Y. I. Miller. 2009. Macrophages generate reactive oxygen species in response to minimally oxidized low-density lipoprotein: Toll-like receptor 4- and spleen tyrosine kinase-dependent activation of NADPH oxidase 2. Circ. Res. 104: 210-218, 21p.
61. Miller, Y. I., S. Viriyakosol, D. S. Worrall, A. Boullier, S. Butler, and J. L. Witztum. 2005. Toll-like receptor 4-dependent and -independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages. Arterioscler. Thromb. Vasc. Biol. 25: 1213-1219.
62. Miller, Y. I., S. Viriyakosol, C. J. Binder, J. R. Feramisco, T. N. Kirkland, and J. L. Witztum. 2003. Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells. J. Biol. Chem. 278: 1561-1568.
63. Zeniou-Meyer, M., N. Zabari, U. Ashery, S. Chasserot-Golaz, A. M. Haeberlé, V. Demais, Y. Bailly, I. Gottfried, H. Nakanishi, A. M. Neiman, et al. 2007. Phospholipase D1 production of phosphatidic acid at the plasma membrane promotes exocytosis of large dense-core granules at a late stage. J. Biol. Chem. 282: 21746-21757.
64. Erridge, C. 2010. Endogenous ligands of TLR2 and TLR4: agonists or assistants? J. Leukoc. Biol. 87: 989-999.
65. Aymeric, L., L. Apetoh, F. Ghiringhelli, A. Tesniere, I. Martins, G. Kroemer, M. J. Smyth, and L. Zitvogel. 2010. Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity. Cancer Res. 70: 855-858.
66. Ghiringhelli, F., L. Apetoh, A. Tesniere, L. Aymeric, Y. Ma, C. Ortiz, K. Vermaelen, T. Panaretakis, G. Mignot, E. Ullrich, et al. 2009. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat. Med. 15: 1170-1178.
67. Martins, I., A. Tesniere, O. Kepp, M. Michaud, F. Schlemmer, L. Senovilla, C. Séror, D. Métivier, J. L. Perfettini, L. Zitvogel, and G. Kroemer. 2009. Chemotherapy induces ATP release from tumor cells. Cell Cycle 8: 3723-3728.